Fake medicines found in NHS supply chain

Pharmacists are calling for tighter legal controls to reduce the risk of patients in the UK being given fake medicines.

Fake medicines in NHS

A report from the School of Pharmacy , in London, points to new figures from the WHO showing that 30 per cent of medicines supplied in developing countries are fake.

In eastern European countries the proportion is 10 per cent, while in wealthier areas such as the UK less than 1 per cent of medicines supplied are counterfeits.

But of the 25 new UK cases being investigated by the Medicines and Healthcare products Regulatory, three involve fake treatments being supplied via the legal NHS medicines supply chain.

Professor David Taylor, author of the Trick or Treat report, said: ‘Compared to the harm done by medicines counterfeiting in Africa and Asia, Europe is relatively safe.

‘But there are growing risks which will get worse if, for example, people believe that they cannot get new medicines that may benefit them for conditions such as cancer, dementia or influenza from publicly funded services.’

The School of Pharmacy report calls for stronger legal penalties for medicine counterfeiting, greater freedom of regulated medicines information provision in Europe, and better controls over internet pharmacy and medicines trading.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in


Just published

Young doctor

BMA poll could see 'demeaning' junior doctor title ditched

The BMA could drop the term 'junior doctor' in favour of 'resident doctor' to better...

Houses of parliament

Tory peer calls PA fears 'Luddism' and claims most GP visits 'incredibly straightforward'

Most GP appointments are 'incredibly straightforward' and fears over a wider role...

UK money

NHS pension contribution overhaul to go ahead from April

Changes to NHS pension contribution rates, which will see the top earners required...

BMA sign

BMA warns £800m lost from GP contract since 2019 as last-ditch talks continue

BMA negotiators remain in talks over an improved GP contract offer for 2024/25 just...

GP consultation

GPs still under pressure to prescribe black triangle drug inclisiran

GPs are continuing to face pressure to prescribe the black triangle drug inclisiran...

BMA chair Professor Phil Banfield

Lords urged to block legislation for GMC to regulate PAs

The BMA has urged peers to block legislation that would make the GMC responsible...